NO20052037L - Doseringsformer med to kjerner og en apning med modifisert frigivelse - Google Patents

Doseringsformer med to kjerner og en apning med modifisert frigivelse

Info

Publication number
NO20052037L
NO20052037L NO20052037A NO20052037A NO20052037L NO 20052037 L NO20052037 L NO 20052037L NO 20052037 A NO20052037 A NO 20052037A NO 20052037 A NO20052037 A NO 20052037A NO 20052037 L NO20052037 L NO 20052037L
Authority
NO
Norway
Prior art keywords
cores
modified release
dosage forms
release aperture
opening
Prior art date
Application number
NO20052037A
Other languages
English (en)
Norwegian (no)
Inventor
David Wynn
Gerard P Mcnally
Harry S Swoden
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/031129 external-priority patent/WO2003026630A1/en
Priority claimed from PCT/US2003/008894 external-priority patent/WO2004028508A1/en
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of NO20052037L publication Critical patent/NO20052037L/no

Links

Landscapes

  • Medicinal Preparation (AREA)
NO20052037A 2002-09-28 2005-04-26 Doseringsformer med to kjerner og en apning med modifisert frigivelse NO20052037L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
PCT/US2002/031129 WO2003026630A1 (en) 2001-09-28 2002-09-28 Dosage forms having an inner core and outer shell with different shapes
PCT/US2002/031024 WO2003026625A1 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031163 WO2003026627A1 (en) 2001-09-28 2002-09-28 Composite dosage forms
PCT/US2002/031062 WO2003026626A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031117 WO2003026629A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2003/008894 WO2004028508A1 (en) 2002-09-28 2003-03-21 Modified release dosage forms with two cores and an opening

Publications (1)

Publication Number Publication Date
NO20052037L true NO20052037L (no) 2005-06-22

Family

ID=35276283

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20052037A NO20052037L (no) 2002-09-28 2005-04-26 Doseringsformer med to kjerner og en apning med modifisert frigivelse
NO20052036A NO20052036L (no) 2002-09-28 2005-04-26 Doseringsform med to kjerner med modifisert frigivelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20052036A NO20052036L (no) 2002-09-28 2005-04-26 Doseringsform med to kjerner med modifisert frigivelse

Country Status (2)

Country Link
MX (3) MXPA05003282A (es)
NO (2) NO20052037L (es)

Also Published As

Publication number Publication date
NO20052036L (no) 2005-06-22
MXPA05003279A (es) 2005-11-23
MXPA05003281A (es) 2005-11-23
MXPA05003282A (es) 2005-11-23

Similar Documents

Publication Publication Date Title
NO20062513L (no) Sammensetninger og doseringsformer for forsterket absorpsjon av metformin
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
NO20054072L (no) Terapeutisk middel for ryggmargsskade omfattende interleukin-6 antagonist.
NO20014986D0 (no) 4,5-diaryl-3(2H)-furanonderivater som cyklooksygenase-2- inhibitorer
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
DK1363608T3 (da) Formuleringer omfattende ibuprofen og diphenhydramin og deres anvendelse til behandling af sovnforstyrrelser
EP1599213A4 (en) CELL MEMBRANE TRANSLOCATION OF SNARE R GUL S INHIBITORS, ASSOCIATED COMPOSITIONS AND PATHOLOGY TREATMENT PROCESSES
YU39800A (sh) Derivati sulfonamida kao pro-lekovi inhibitora aspartil proteaze
WO2011061330A3 (de) Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
DE602005007188D1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
CR10032A (es) Preparación sólida
WO2003016335A3 (en) Irreversible cysteine protease inhibitors of legumain
DK1296972T3 (da) Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer
NO951498L (no) Farmasöytisk preparat for behandling av osteoporose
NO20084276L (no) Orodispergerbare domperidontabletter
NO20055367L (no) Kombinasjoner som innbefatter paroksetin og 2-(S)-4-fluor-2-metyl-fenyl)-piperazin-1-karboksylsyer (1-(R)-(3,5-bis-trifluor-2-metyl-fenyl)-etyl]metylamid for behandling av depresjon og/eller angst
NO20076405L (no) Anvendelse av 24-nor-UDCA
WO2005105081A3 (en) Therapeutic formulations of desoxyepothilones
ATE324112T1 (de) Topische behandlung bei der mastalgie
NO20073575L (no) Farmasoytiske sammensetninger for behandling av cellulitt
WO2005052140A3 (en) Multipotent postnatal stem cells from human periodontal ligament and uses thereof
BR0314804A (pt) Forma de dosagem de liberação modificada
FR2848851B1 (fr) Procede d'obtention d'un principe actif presentant des capacites apaisantes, principe actif et compositions obtenues

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application